The new facility is dedicated to the comprehensive diagnosis, treatment, and rehabilitation of balance and vertigo disorders, ...

Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré ...